Characteristic clinicopathological features of the types of intraductal papillary-mucinous neoplasms of the pancreas

Pancreas

Volumn 35, Issue 4, 2007, Pages 348-352

  Ishida, Masaharu ^a   Egawa, Shinichi ^a   Aoki, Takeshi ^a   Sakata, Naoaki ^a   Mikami, Yukio ^a   Motoi, Fuyuhiko ^a   Abe, Tadayoshi ^a   Fukuyama, Shoji ^a   Sunamura, Makoto ^b,c   Unno, Michiaki ^a   Moriya, Takuya ^d   Horii, Akira ^e   Furukawa, Toru ^e,f  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

^c TEIKYO UNIVERSITY   (Japan)

^d TOHOKU UNIVERSITY HOSPITAL   (Japan)

^e TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Clinicopathological feature; Histological type; IPMN; MUC; Pancreatic cancer; Prognosis

Indexed keywords

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; DATA ANALYSIS; DISEASE ASSOCIATION; DISEASE CLASSIFICATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTRADUCTAL PAPILLARY MUCINOUS TUMOR; MALE; PANCREAS CANCER; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; STATISTICAL SIGNIFICANCE; UNIVERSITY HOSPITAL;

ADENOCARCINOMA; ADENOCARCINOMA, MUCINOUS; ADENOMA; AGED; CA-15-3 ANTIGEN; CARCINOMA, PANCREATIC DUCTAL; CARCINOMA, PAPILLARY; FEMALE; HUMANS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; MUCINS; NEOPLASM INVASIVENESS; PANCREATIC DUCTS; PANCREATIC NEOPLASMS; PROGNOSIS; RETROSPECTIVE STUDIES;

EID: 37349088610     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: 10.1097/mpa.0b013e31806da090     Document Type: Article

References (7)

1. Kawarada Y, Japan Pancreas Society. Classification of Pancreatic Carcinoma, 2nd ed. Tokyo: Kanehara & Co, Ltd; 2003.
2. Hruban RH, Takaori K, Klimstra DS, et al. An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms. Am J Surg Pathol. 2004;28:977-987.
3. Ohhashi K, Murakami Y, Maruyama M, et al. Four cases of mucous secreting pancreatic cancer. Prog Digest Endosc. 1982;20:348-351.
4. Furukawa T, Kloppel G, Volkan Adsay N, et al. Classification of types of intraductal papillary-mucinous neoplasm of the pancreas: a consensus study. Virchows Arch. 2005;447:794-799.
5. Furukawa T, Takahashi T, Kobari M, et al. The mucus-hypersecreting tumor of the pancreas. Development and extension visualized by three-dimensional computerized mapping. Cancer. 1992;70:1505-1513.
6. Adsay NV, Merati K, Andea A, et al. The dichotomy in the preinvasive neoplasia to invasive carcinoma sequence in the pancreas: differential expression of MUC1 and MUC2 supports the existence of two separate pathways of carcinogenesis. Mod Pathol. 2002;15:1087-1095.
7. Kobari M, Egawa S, Shibuya K, et al. Intraductal papillary mucinous tumors of the pancreas comprise 2 clinical subtypes: differences in clinical characteristics and surgical management. Arch Surg. 1999;134:1131-1136.